A change in the wording of antibiotic duration orders for neonatal sepsis led to a substantial decrease in the number of infants who received extra unnecessary antibiotic orders, pharmacists at a hospital in British Columbia reported today in the American Journal of Infection Control.
The Infectious Diseases Society of America (IDSA) and five other medical organizations are urging changes to a national set of care measures for sepsis patients, with the aim of reducing unnecessary antibiotic use in patients who may not need them.
A new analysis of data from a randomized clinical trial that found that mass distribution of the antibiotic azithromycin to children under 5 years old was associated with reduced childhood mortality in three African countries suggests mortality reduction may be linked to effects on pneumonia, diarrhea, or HIV/AIDS mortality.
The savings could rise significantly if more accurate diagnostic tests were available, the authors say.
The phenotypic tests measure nucleic acid in bacteria after exposure to antibiotics.
A computerized clinical support tool implemented at an academic medical center helped reduce rates of Clostridioides difficile testing without an associated increase in adverse events in patients whose tests were prevented, researchers from the University of Virginia (UVA) School of Medicine reported today in Open Forum Infectious Diseases.
As of Mar 2, the United States so far this year has recorded 12 measles cases from 7 jurisdictions, the Centers for Disease Control and Prevention (CDC) said in a Mar 12 monthly update. The totals reflect an increase of 7 cases and 2 jurisdictions since the CDC's last update on Feb 3.
A new study by researchers from Harvard TH Chan School of Public Health suggests that outpatient prescribing of penicillins is associated with rates of mortality with sepsis in older US adults.
The United Kingdom's Food Standards Agency (FSA) released two surveillance reports this week on antimicrobial resistance (AMR) in chicken meat.
The United Kingdom yesterday announced the launch of a partnership with Nigeria, worth £10.7 million, to fight antimicrobial resistance (AMR) by improving public health surveillance, upgrading laboratory equipment, and training technicians.
